Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Director's Dealing 2008

Apr 1, 2008

6990_dirs_2008-04-01_117a2711-0208-4281-9a11-34648fceb31d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2007-11-14

Reporting Person: ROSMAN NACHUM (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-11-14 Stock options(right to buy) $6.8 A 36250 Acquired 2017-11-13 Common stock (36250) Direct

Footnotes

F1: The number of options and the exercise price are after the effect of the 1 for 200 reverse split that occurred on November
26, 2007.

F2: The options vest as follows: 25% on the six month anniversary of the date of grant, 4% on the 7 month and each successive
month anniversary to and including the 23rd month anniversary and the balance on the 24 month anniversary.

F3: The option was granted in recognition of services provided by the reporting person.